These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

40 related articles for article (PubMed ID: 3788196)

  • 1. Systemic therapy of breast cancer.
    Davis HL
    Wis Med J; 1986 Aug; 85(8):22-4. PubMed ID: 3788196
    [No Abstract]   [Full Text] [Related]  

  • 2. Adjuvant chemotherapy for breast cancer.
    Schnipper LE; Come SE
    Compr Ther; 1980 Oct; 6(10):42-7. PubMed ID: 7449364
    [No Abstract]   [Full Text] [Related]  

  • 3. Evolving concepts in the systemic drug therapy of breast cancer.
    Norton L
    Semin Oncol; 1997 Aug; 24(4 Suppl 10):S10-3-S10-10. PubMed ID: 9275000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinical features and managements of breast cancer patients with pulmonary metastasis].
    Horikoshi N; Inagaki J; Ezaki K; Inoue K; Ogawa M
    Gan No Rinsho; 1983 May; 29(6):538-43. PubMed ID: 6876422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic factors in metastatic breast cancer.
    Fey MF; Brunner KW; Sonntag RW
    Cancer Clin Trials; 1981; 4(3):237-47. PubMed ID: 7285274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The sound and the fury: an update on the role of high-dose chemotherapy and autologous stem cell salvage for both metastatic and high-risk breast cancer.
    Bar MH
    Conn Med; 2000 Jan; 64(1):3-6. PubMed ID: 10697358
    [No Abstract]   [Full Text] [Related]  

  • 7. Comment on "The methodologic dilemma in retrospectively correlating the amount of chemotherapy received in adjuvant therapy protocols with disease-free survival".
    Bonadonna G; Valagussa P
    Cancer Treat Rep; 1983 Jun; 67(6):527-9. PubMed ID: 6688038
    [No Abstract]   [Full Text] [Related]  

  • 8. Adjuvant systemic therapy in primary breast cancer.
    Mouridsen HT; Palshof T
    Acta Chir Scand Suppl; 1984; 519():43-53. PubMed ID: 6393664
    [No Abstract]   [Full Text] [Related]  

  • 9. The case for adjuvant CMF chemotherapy in breast cancer. Has it been made?
    Levitt SH; Potish RA
    Cancer Clin Trials; 1981; 4(4):363-9. PubMed ID: 7032731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Place of hormone receptor determination in the therapeutic strategy of breast cancer].
    Clavel B; Gest J
    Pathol Biol (Paris); 1983 Dec; 31(10):809-18. PubMed ID: 6366702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [State of the art of drug therapy in breast cancer].
    Watanabe T
    Gan To Kagaku Ryoho; 1993 Dec; 20(16):2437-46. PubMed ID: 8279839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-dose chemotherapy for breast cancer.
    Gratwohl A; Baldomero H; Rosti G
    Bone Marrow Transplant; 2000 Sep; 26(6):599. PubMed ID: 11041563
    [No Abstract]   [Full Text] [Related]  

  • 13. Expression of prostate-specific antigen (PSA) correlates with poor response to tamoxifen therapy in recurrent breast cancer.
    Foekens JA; Diamandis EP; Yu H; Look MP; Meijer-van Gelder ME; van Putten WL; Klijn JG
    Br J Cancer; 1999 Feb; 79(5-6):888-94. PubMed ID: 10070886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mega-dose vitamin and mineral therapy in breast cancer: a clinician's perspective.
    Block KI
    Integr Cancer Ther; 2003 Jun; 2(2):163-5. PubMed ID: 15035906
    [No Abstract]   [Full Text] [Related]  

  • 15. Cancer trends: surgical adjuvant chemotherapy for operable breast cancer.
    Horsley JS; Diasio RB
    Va Med; 1980 Nov; 107(11):781-4. PubMed ID: 7434892
    [No Abstract]   [Full Text] [Related]  

  • 16. Conceptual basis for advances in the systemic drug therapy of breast cancer.
    Norton L
    Semin Oncol; 1997 Aug; 24(4 Suppl 11):S11-2-S11-12. PubMed ID: 9314292
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic significance of a combined clinicopathologic score for response to primary systemic therapy in locally advanced breast cancer.
    Bertheau P; Lerebours F; Mounier N; de Roquancourt A; Espié M; Clot P; Servant JM; Misset JL; Marty M; Janin A
    Oncol Rep; 2005 Aug; 14(2):513-20. PubMed ID: 16012739
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase I--II evaluation of combination cyclophosphamide, 5-fluorouracil, hexamethylmelamine, and prednisone in advanced breast cancer.
    Chang YC; Falkson G; Tormey DC; Crowley J
    Cancer Clin Trials; 1981; 4(4):377-80. PubMed ID: 6797746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Breast cancer trials--a new initiative.
    Br Med J (Clin Res Ed); 1981 Feb; 282(6263):562-4. PubMed ID: 6780125
    [No Abstract]   [Full Text] [Related]  

  • 20. Hormonal receptors and response to treatment of breast cancer: a retrospective evaluation in 60 patients.
    Loven D; Rakowsky E; Stein JA; Geier A; Lunenfeld B
    Isr J Med Sci; 1981; 17(9-10):960-4. PubMed ID: 7309485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.